Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Patient-Reported Symptoms in Facioscapulohumeral Muscular Dystrophy (PRISM-FSHD).

Hamel J, Johnson N, Tawil R, Martens WB, Dilek N, McDermott MP, Heatwole C.

Neurology. 2019 Sep 17;93(12):e1180-e1192. doi: 10.1212/WNL.0000000000008123. Epub 2019 Aug 13.

PMID:
31409737
2.

The relationship between total atrial conduction time and left atrial global strain in patients with psoriasis vulgaris.

Duman H, Dilek N, Demirelli S, Inci S, Duman H, Çetin M, Durakoğlugil ME.

Arch Med Sci. 2019 Jul;15(4):865-871. doi: 10.5114/aoms.2019.82678. Epub 2019 Jan 30.

3.

SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells.

Pengam S, Durand J, Usal C, Gauttier V, Dilek N, Martinet B, Daguin V, Mary C, Thepenier V, Teppaz G, Renaudin K, Blancho G, Vanhove B, Poirier N.

Am J Transplant. 2019 Jun 17. doi: 10.1111/ajt.15497. [Epub ahead of print]

PMID:
31207067
4.

Decreased left atrial strain parameters are associated with prolonged total atrial conduction time in lichen planus.

Duman H, Dilek N, Değirmenci H, Duman H, Tüfekçi D, Uslu A, Şatiroğlu Ö, Çiçek Y.

Interv Med Appl Sci. 2018 Sep;10(3):150-156. doi: 10.1556/1646.10.2018.11.

5.

Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA).

Mongiovi P, Dilek N, Garland C, Hunter M, Kissel JT, Luebbe E, McDermott MP, Johnson N, Heatwole C.

Neurology. 2018 Sep 25;91(13):e1206-e1214. doi: 10.1212/WNL.0000000000006241. Epub 2018 Aug 24.

6.

The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome.

Johnson NE, Heatwole C, Creigh P, McDermott MP, Dilek N, Hung M, Bounsanga J, Tang W, Shy ME, Herrmann DN.

Ann Neurol. 2018 Aug;84(2):225-233. doi: 10.1002/ana.25282. Epub 2018 Aug 29.

7.

Recurrent candidal intertrigo: challenges and solutions.

Metin A, Dilek N, Bilgili SG.

Clin Cosmet Investig Dermatol. 2018 Apr 17;11:175-185. doi: 10.2147/CCID.S127841. eCollection 2018. Review.

8.

Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.

Mul K, Heatwole C, Eichinger K, Dilek N, Martens WB, Van Engelen BGM, Tawil R, Statland JM.

Muscle Nerve. 2018 Aug;58(2):213-218. doi: 10.1002/mus.26127. Epub 2018 Apr 17.

9.

Facioscapulohumeral muscular dystrophy functional composite outcome measure.

Eichinger K, Heatwole C, Iyadurai S, King W, Baker L, Heininger S, Bartlett A, Dilek N, Martens WB, Mcdermott M, Kissel JT, Tawil R, Statland JM.

Muscle Nerve. 2018 Jan 30. doi: 10.1002/mus.26088. [Epub ahead of print]

10.

Myotonic dystrophy patient preferences in patient-reported outcome measures.

Heatwole C, Johnson N, Dekdebrun J, Dilek N, Eichinger K, Hilbert J, Luebbe E, Martens W, Mcdermott MP, Thornton C, Moxley R.

Muscle Nerve. 2018 Jan 12. doi: 10.1002/mus.26066. [Epub ahead of print]

PMID:
29328504
11.

Epidemiology of Pemphigus in Turkey: One-year Prospective Study of 220 Cases.

Yayli S, Harman M, Baskan EB, Karakas AA, Genc Y, Turk BG, Demirsoy EO, Gunasti S, Bilgili SG, Ilter N, Ferahbas A, Savk E, Afsar FS, Aytekin S, Kaya TI, Hayta SB, Ozgen Z, Gurel MS, Caliskan E, Balci DD, Gungor S, Kapicioglu Y, Ozuguz P, Aktan S, Dogramaci A, Kokcam I, Onsun N, Seckin D, Durdu M, Dursun R, Daye M, Dilek N, Karabacak E, Temel AB, Erdem C, Altun E, Gungor D, Kartal D, Akyol M, Koku Aksu EK, Uzun S.

Acta Dermatovenerol Croat. 2017 Oct;25(3):181-188.

PMID:
29252169
12.

Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the Fuel.

Irving M, Vuillefroy de Silly R, Scholten K, Dilek N, Coukos G.

Front Immunol. 2017 Apr 3;8:267. doi: 10.3389/fimmu.2017.00267. eCollection 2017. Review.

13.
14.

Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis.

Dilek N, Dilek AR, Taşkın Y, Erkinüresin T, Yalçın Ö, Saral Y.

Postepy Dermatol Alergol. 2016 Dec;33(6):435-439. doi: 10.5114/ada.2016.63882. Epub 2016 Dec 2.

15.

In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI.

Gonzales C, Yoshihara HA, Dilek N, Leignadier J, Irving M, Mieville P, Helm L, Michielin O, Schwitter J.

PLoS One. 2016 Oct 13;11(10):e0164557. doi: 10.1371/journal.pone.0164557. eCollection 2016.

16.

Evaluation of the relationship between c-Kit expression and mean platelet volume in classic Kaposi's sarcoma.

Sehitoglu I, Bedir R, Cure E, Cure MC, Yuce S, Dilek N.

An Bras Dermatol. 2016 Jul-Aug;91(4):430-5. doi: 10.1590/abd1806-4841.20164331.

17.

1,2,3-Triazoles as inhibitors of indoleamine 2,3-dioxygenase 2 (IDO2).

Röhrig UF, Majjigapu SR, Caldelari D, Dilek N, Reichenbach P, Ascencao K, Irving M, Coukos G, Vogel P, Zoete V, Michielin O.

Bioorg Med Chem Lett. 2016 Sep 1;26(17):4330-3. doi: 10.1016/j.bmcl.2016.07.031. Epub 2016 Jul 16.

PMID:
27469130
18.

Crystal structure of trans-di-aqua-bis-(nicotinamide-κN (1))bis-(4-nitro-benzoato-κO)manganese(II).

Aşkın GŞ, Necefoğlu H, Tonbul AM, Dilek N, Hökelek T.

Acta Crystallogr E Crystallogr Commun. 2016 Apr 8;72(Pt 5):656-8. doi: 10.1107/S2056989016005612. eCollection 2016 May 1.

19.

Electrical impedance myography in facioscapulohumeral muscular dystrophy.

Statland JM, Heatwole C, Eichinger K, Dilek N, Martens WB, Tawil R.

Muscle Nerve. 2016 Oct;54(4):696-701. doi: 10.1002/mus.25065. Epub 2016 May 25.

20.

PRENATAL DIAGNOSIS OF RHIZOMELIC CHONDRODYSPLASIA PUNCTATA.

Erdogdu E, Dilek N, Arisoy R, Tahaoglu AE, Karacor T, Andan C.

Genet Couns. 2016;27(4):533-535. No abstract available.

PMID:
30226976
21.

Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates.

Poirier N, Chevalier M, Mary C, Hervouet J, Minault D, Baker P, Ville S, Le Bas-Bernardet S, Dilek N, Belarif L, Cassagnau E, Scobie L, Blancho G, Vanhove B.

J Immunol. 2016 Jan 1;196(1):274-83. doi: 10.4049/jimmunol.1501810. Epub 2015 Nov 23.

22.

Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).

Heatwole C, Johnson N, Bode R, Dekdebrun J, Dilek N, Hilbert JE, Luebbe E, Martens W, McDermott MP, Quinn C, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT 3rd.

Neurology. 2015 Dec 15;85(24):2136-46. doi: 10.1212/WNL.0000000000002225. Epub 2015 Nov 18.

23.

Crystal structure of tetra-kis-(μ-2,4,6-tri-methyl-benzoato-κ(2) O:O')bis-[(nicotinamide-κN (1))copper(II)].

Aşkın GŞ, Necefoğlu H, Özkaya S, Dilek N, Hökelek T.

Acta Crystallogr E Crystallogr Commun. 2015 Jul 31;71(Pt 8):989-92. doi: 10.1107/S2056989015013882. eCollection 2015 Aug 1.

24.

Fungal infections of the folds (intertriginous areas).

Metin A, Dilek N, Demirseven DD.

Clin Dermatol. 2015 Jul-Aug;33(4):437-47. doi: 10.1016/j.clindermatol.2015.04.005. Epub 2015 Apr 7. Review.

PMID:
26051058
25.

Myotonic dystrophy health index: Correlations with clinical tests and patient function.

Heatwole C, Bode R, Johnson NE, Dekdebrun J, Dilek N, Eichinger K, Hilbert JE, Logigian E, Luebbe E, Martens W, Mcdermott MP, Pandya S, Puwanant A, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley RT 3rd.

Muscle Nerve. 2016 Feb;53(2):183-90. doi: 10.1002/mus.24725. Epub 2015 Dec 29.

26.

Crystal structure of catena-poly[[aqua-bis-(4-formyl-benzoato)-κ(2) O (1),O (1');κO (1)-zinc]-μ-pyrazine-κ(2) N:N'].

Aşkın GŞ, Çelik F, Dilek N, Necefoğlu H, Hökelek T.

Acta Crystallogr E Crystallogr Commun. 2015 Mar 21;71(Pt 4):402-5. doi: 10.1107/S2056989015005472. eCollection 2015 Apr 1.

27.

Crystal structure of catena-poly[[di-aqua-bis-(4-formyl-benzoato-κO (1))cobalt(II)]-μ-pyrazine-κ(2) N:N'].

Aşkın GŞ, Çelik F, Dilek N, Necefoğlu H, Hökelek T.

Acta Crystallogr E Crystallogr Commun. 2015 Mar 4;71(Pt 4):339-41. doi: 10.1107/S205698901500403X. eCollection 2015 Apr 1.

28.

Crystal structure of poly[bis-(μ-nicotinamide-κ(2) N (1):O)bis-(μ-4-nitro-benzoato-κ(2) O (1):O (1'))zinc].

Aşkın GŞ, Necefoğlu H, Tonbul AM, Dilek N, Hökelek T.

Acta Crystallogr E Crystallogr Commun. 2015 Apr 11;71(Pt 5):479-82. doi: 10.1107/S2056989015006490. eCollection 2015 May 1.

29.

The importance of cytokeratin 19 expression in the differentiation of Basal cell carcinoma and trichoepithelioma.

Bedir R, Sehitoglu I, Yurdakul C, Saygin I, Üstüner P, Dilek N.

J Clin Diagn Res. 2015 Jan;9(1):EC01-4. doi: 10.7860/JCDR/2015/10915.5414. Epub 2015 Jan 1.

30.

Synthesis, structural characterization and DNA interaction of zinc complex from 2,6-diacetylpyridine dihydrazone and {4-[(2E)-2-(hydroxyimino)acetyl]phenoxy} acetic acid.

Gup R, Gökçe C, Dilek N.

J Photochem Photobiol B. 2015 Mar;144:42-50. doi: 10.1016/j.jphotobiol.2015.02.002. Epub 2015 Feb 11.

PMID:
25704313
31.

Bortezomib, C1-inhibitor and plasma exchange do not prolong the survival of multi-transgenic GalT-KO pig kidney xenografts in baboons.

Le Bas-Bernardet S, Tillou X, Branchereau J, Dilek N, Poirier N, Châtelais M, Charreau B, Minault D, Hervouet J, Renaudin K, Crossan C, Scobie L, Takeuchi Y, Diswall M, Breimer ME, Klar N, Daha MR, Simioni P, Robson SC, Nottle MB, Salvaris EJ, Cowan PJ, d'Apice AJ, Sachs DH, Yamada K, Lagutina I, Duchi R, Perota A, Lazzari G, Galli C, Cozzi E, Soulillou JP, Vanhove B, Blancho G.

Am J Transplant. 2015 Feb;15(2):358-70. doi: 10.1111/ajt.12988.

32.

Cutaneous drug reactions in children: a multicentric study.

Dilek N, Özkol HU, Akbaş A, Kılınç F, Dilek AR, Saral Y, Metin A, Çalka Ö.

Postepy Dermatol Alergol. 2014 Dec;31(6):368-71. doi: 10.5114/pdia.2014.43881. Epub 2014 Dec 3.

33.

FR104, an antagonist anti-CD28 monovalent fab' antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft.

Poirier N, Dilek N, Mary C, Ville S, Coulon F, Branchereau J, Tillou X, Charpy V, Pengam S, Nerriere-Daguin V, Hervouet J, Minault D, Le Bas-Bernardet S, Renaudin K, Vanhove B, Blancho G.

Am J Transplant. 2015 Jan;15(1):88-100. doi: 10.1111/ajt.12964. Epub 2014 Dec 8.

34.

Hepcidin expression in psoriasis patients.

Dilek N, Dilek AR, Sahin K, Kaklıkkaya N, Saral Y.

Indian J Dermatol. 2014 Nov;59(6):630. doi: 10.4103/0019-5154.143564.

35.

DFT calculations, spectroscopy and antioxidant activity studies on (E)-2-nitro-4-[(phenylimino)methyl]phenol.

Temel E, Alaşalvar C, Gökçe H, Güder A, Albayrak Ç, Alpaslan YB, Alpaslan G, Dilek N.

Spectrochim Acta A Mol Biomol Spectrosc. 2015 Feb 5;136 Pt B:534-46. doi: 10.1016/j.saa.2014.09.067. Epub 2014 Oct 2.

PMID:
25448954
36.

Pemphigoid gestationis in a third trimester pregnancy.

Sentürk S, Dilek N, Tekin YB, Colak S, Gündoğdu B, Güven ES.

Case Rep Obstet Gynecol. 2014;2014:127628. doi: 10.1155/2014/127628. Epub 2014 Nov 9.

37.

Unilateral pityriasis rosea.

Ataseven A, Kurtipek GS, Akyurek FT, Kucukosmanoglu I, Dilek N.

Indian Dermatol Online J. 2014 Oct;5(4):528-9. doi: 10.4103/2229-5178.142550. No abstract available.

38.

Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspective.

Johnson NE, Heatwole CR, Dilek N, Sowden J, Kirk CA, Shereff D, Shy ME, Herrmann DN; Inherited Neuropathies Consortium.

Neuromuscul Disord. 2014 Nov;24(11):1018-23. doi: 10.1016/j.nmd.2014.06.433. Epub 2014 Jun 27.

39.

Prospective study of muscle cramps in Charcot-Marie-tooth disease.

Johnson NE, Sowden J, Dilek N, Eichinger K, Burns J, Mcdermott MP, Shy ME, Herrmann DN.

Muscle Nerve. 2015 Apr;51(4):485-8. doi: 10.1002/mus.24333. Epub 2015 Feb 11.

40.

Molecular structure, quantum mechanical calculation and radical scavenging activities of (E)-4,6-dibromo-2-[(3,5-dimethylphenylimino)methyl]-3-methoxyphenol and (E)-4,6-dibromo-2-[(2,6-dimethylphenylimino)methyl]-3-methoxyphenol compounds.

Alaşalvar C, Soylu MS, Güder A, Albayrak Ç, Apaydın G, Dilek N.

Spectrochim Acta A Mol Biomol Spectrosc. 2014 Sep 15;130:357-66. doi: 10.1016/j.saa.2014.03.069. Epub 2014 Apr 13.

PMID:
24810021
41.

(4,9-Dimethyl-9H-carbazol-3-yl)meth-anol.

Oncüoğlu S, Dilek N, Ergün Y, Hökelek T.

Acta Crystallogr Sect E Struct Rep Online. 2014 Feb 22;70(Pt 3):o346-7. doi: 10.1107/S1600536814003845. eCollection 2014 Mar 1.

42.

Ethyl 4,9-dimethyl-9H-carbazole-3-carboxyl-ate.

Oncüoğlu S, Dilek N, Caylak Delibaş N, Ergün Y, Hökelek T.

Acta Crystallogr Sect E Struct Rep Online. 2014 Feb 5;70(Pt 3):o240. doi: 10.1107/S1600536814002098. eCollection 2014 Mar 1.

43.

catena-Poly[[di-aqua-bis-(4-formyl-benzo-ato-κO (1))nickel(II)]-μ-pyrazine-κ(2) N:N'].

Celik F, Dilek N, Caylak Delibaş N, Necefoğlu H, Hökelek T.

Acta Crystallogr Sect E Struct Rep Online. 2014 Jan 25;70(Pt 2):m65-6. doi: 10.1107/S160053681400155X. eCollection 2014 Feb 1.

44.

catena-Poly[[aqua-bis-(4-formyl-benzoato-κ(2) O (1),O (1'))cadmium]-μ-pyrazine-κ(2) N:N'].

Celik F, Dilek N, Caylak Delibaş N, Necefoğlu H, Hökelek T.

Acta Crystallogr Sect E Struct Rep Online. 2014 Jan 11;70(Pt 2):m37-8. doi: 10.1107/S1600536813035010. eCollection 2014 Feb 1.

45.

Comparative experimental and theoretical studies of N-(4-Methylbenzylidene)-N'-(2-carboxyphenyl) hydrazine novel Schiff base.

Tunç T, Tezcan H, Sağlam S, Dilek N.

Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jun 5;127:490-7. doi: 10.1016/j.saa.2014.02.104. Epub 2014 Mar 4.

PMID:
24657931
46.

Crystal structure, DFT and HF calculations and radical scavenging activities of (E)-4,6-dibromo-3-methoxy-2-[(3-methoxyphenylimino)methyl]phenol.

Alaşalvar C, Soylu MS, Güder A, Albayrak Ç, Apaydın G, Dilek N.

Spectrochim Acta A Mol Biomol Spectrosc. 2014 May 5;125:319-27. doi: 10.1016/j.saa.2014.01.104. Epub 2014 Feb 7.

PMID:
24566110
47.

catena-Poly[[di-aqua-bis-(4-formyl-benzoato-κO (1))copper(II)]-μ-pyrazine-κ(2) N:N'].

Celik F, Dilek N, Caylak Delibaş N, Necefoğlu H, Hökelek T.

Acta Crystallogr Sect E Struct Rep Online. 2013 Dec 7;70(Pt 1):m4-5. doi: 10.1107/S1600536813032297. eCollection 2014 Jan 1.

48.

Epidermoid cyst on the nipple: a rare location.

Dilek N, Dilek AR, Saral Y, Şehitoğlu I.

Breast J. 2014 Mar-Apr;20(2):203-4. doi: 10.1111/tbj.12243. Epub 2014 Jan 9. No abstract available.

PMID:
24405334
49.

Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.

Dilek N, Poirier N, Hulin P, Coulon F, Mary C, Ville S, Vie H, Clémenceau B, Blancho G, Vanhove B.

PLoS One. 2013 Dec 23;8(12):e83139. doi: 10.1371/journal.pone.0083139. eCollection 2013.

50.

Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure.

Heatwole C, Bode R, Johnson N, Dekdebrun J, Dilek N, Heatwole M, Hilbert JE, Luebbe E, Martens W, Mcdermott MP, Rothrock N, Thornton C, Vickrey BG, Victorson D, Moxley R 3rd.

Muscle Nerve. 2014 Jun;49(6):906-14. doi: 10.1002/mus.24097.

Supplemental Content

Support Center